Septerna (SEPN) Gains from Investment Securities (2023 - 2026)
Septerna's quarterly Gains from Investment Securities came in at -$3000.0 in Q1 2026, down 100.99% year-on-year from $304400.0 in Q1 2025, and up 99.77% quarter-over-quarter from -$1.3 million in Q4 2025.
Septerna has reported Gains from Investment Securities for 4 years, with the latest figure at -$3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 100.99% year-over-year to -$3000.0; the trailing twelve-month figure through Mar 2026 stood at -$303000.0 (down 199.54% YoY), and the FY2025 full-year result was $4.4 million, up 48.98% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$3000.0, up from -$1.3 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $12.6 million in Q4 2023, with the low at -$12.2 million in Q4 2024.
- Average Gains from Investment Securities over 4 years is $42508.1, with a median of $23227.0 recorded in 2024.
- Year-over-year, Gains from Investment Securities slumped 197.19% in 2024 and jumped 2483.2% in 2025.
- Tracing SEPN's Gains from Investment Securities over 4 years: stood at $12.6 million in 2023, then plunged by 197.19% to -$12.2 million in 2024, then soared by 89.37% to -$1.3 million in 2025, then jumped by 99.77% to -$3000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$3000.0 (Q1 2026), -$1.3 million (Q4 2025), and $600000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -1.30 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 304,400.00 |
| Mar 31, 2025 | 304,400.00 |
| Dec 31, 2024 | -12.23 Mn |
| Dec 31, 2024 | -12.23 Mn |
| Sep 30, 2024 | 23,227.00 |
| Sep 30, 2024 | 23,227.00 |
| Jun 30, 2024 | 23,227.00 |
| Jun 30, 2024 | 23,227.00 |
| Mar 31, 2024 | 23,227.00 |
| Mar 31, 2024 | 23,227.00 |
| Dec 31, 2023 | 12.58 Mn |
| Dec 31, 2023 | 12.58 Mn |